Engineering targeted nanomedicines for advanced prostate cancer
Prostate cancer is one of the most common types of cancer. Prostate cancer treatment protocols include the use of androgen deprivation therapy (ADT) and docetaxel which have high resistance rate in advanced disease stages. XD19 is a novel compound showed a promising activity on C4-2B prostate cancer...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10889/13586 |
